YU4198A - Karbapenem antibiotik, kompozicija i postupak za dobijanje - Google Patents

Karbapenem antibiotik, kompozicija i postupak za dobijanje

Info

Publication number
YU4198A
YU4198A YU4198A YU4198A YU4198A YU 4198 A YU4198 A YU 4198A YU 4198 A YU4198 A YU 4198A YU 4198 A YU4198 A YU 4198A YU 4198 A YU4198 A YU 4198A
Authority
YU
Yugoslavia
Prior art keywords
composition
preparation
carbapenem antibiotic
carbapenem
antibiotic
Prior art date
Application number
YU4198A
Other languages
English (en)
Inventor
Jeffrey Zimmerman
M. John Williams
A. Paul Bergquist
M. Lisa Di Michele
C. David Dubost
J. Michael Kaufman
R. Danile Sidler
A. William Hunke
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU4198(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9612668.5A external-priority patent/GB9612668D0/en
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of YU4198A publication Critical patent/YU4198A/sh
Publication of RS49583B publication Critical patent/RS49583B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/887Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Opisana je farmaceutska kompozicija koja sadrži jedinejnje formule I ili njegovu farmaceutski prihvatljivu so, pro-lek ili hidrat, u stabilizovanom obliku i/ili u kombinaciji sa izvorom ugljen dioksida.
YUP-41/98A 1996-05-28 1997-05-23 Karbapenem antibiotik, kompozicija i postupak za dobijanje RS49583B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1851896P 1996-05-28 1996-05-28
GBGB9612668.5A GB9612668D0 (en) 1996-06-18 1996-06-18 Carbapenem antibiotic composition and method of preparation

Publications (2)

Publication Number Publication Date
YU4198A true YU4198A (sh) 1998-12-23
RS49583B RS49583B (sr) 2007-04-10

Family

ID=26309530

Country Status (34)

Country Link
EP (1) EP0863901B1 (sh)
JP (2) JPH11509871A (sh)
KR (2) KR100403497B1 (sh)
CN (1) CN1067074C (sh)
AT (1) ATE252584T1 (sh)
AU (1) AU710102B2 (sh)
BG (1) BG63821B1 (sh)
CA (1) CA2227994C (sh)
CO (1) CO4940412A1 (sh)
CY (1) CY2437B1 (sh)
CZ (1) CZ296381B6 (sh)
DE (1) DE69725696T2 (sh)
DK (1) DK0863901T3 (sh)
DZ (1) DZ2242A1 (sh)
EA (1) EA000534B1 (sh)
EE (1) EE04678B1 (sh)
ES (1) ES2208907T3 (sh)
HK (1) HK1016176A1 (sh)
HR (1) HRP970281B1 (sh)
HU (1) HU229426B1 (sh)
ID (1) ID16974A (sh)
IL (1) IL123078A (sh)
IS (1) IS2353B (sh)
MX (1) MX9800808A (sh)
NO (1) NO323815B1 (sh)
NZ (1) NZ329649A (sh)
PL (1) PL188917B1 (sh)
PT (1) PT863901E (sh)
RS (1) RS49583B (sh)
SI (1) SI0863901T1 (sh)
SK (1) SK284359B6 (sh)
TR (1) TR199800146T1 (sh)
TW (1) TW434014B (sh)
WO (1) WO1997045430A1 (sh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018800A1 (en) * 1996-10-28 1998-05-07 Merck & Co., Inc. Stabilized carbapenem antibiotic compositions and method of making
NZ500955A (en) * 1997-06-16 2001-06-29 Merck & Co Inc Stabilized 1-beta-methyl-carbapenem intermediates and synthetic use
US6180783B1 (en) * 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
US6504027B1 (en) 1998-03-02 2003-01-07 Merck & Co., Inc. Decarboxylation process for synthesizing carbapenem antibiotics
WO2001032172A1 (en) * 1999-10-29 2001-05-10 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
AR035728A1 (es) 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
CN101357918B (zh) * 2007-06-22 2011-05-18 山东轩竹医药科技有限公司 含有异硫脲基巯基吡咯烷的培南衍生物
CN101367815B (zh) * 2007-06-28 2012-07-04 山东轩竹医药科技有限公司 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物
EP2229944A1 (en) 2007-12-12 2010-09-22 Dainippon Sumitomo Pharma Co., Ltd. Preparation composition
CN101550138B (zh) * 2008-04-03 2011-05-18 山东轩竹医药科技有限公司 巯基氮杂环烷酰胺醇取代的培南衍生物
EP2505190A1 (en) * 2008-06-11 2012-10-03 Ranbaxy Laboratories Limited Polymorphic forms of ertapenem monosodium salt and process for it's preparation
EP2415758B1 (en) 2009-03-31 2017-03-01 Mitsubishi Materials Electronic Chemicals Co., Ltd. Fluorine-containing n-alkyl sulfonyl imide compound, manufacturing method therefor, and method of manufacturing an ionic compound
CN102803649A (zh) 2009-06-25 2012-11-28 国际壳牌研究有限公司 注水系统和方法
US8889384B2 (en) 2010-10-07 2014-11-18 Shell Oil Company Process for the production of alcohols from biomass
CN103189526B (zh) 2010-11-05 2015-07-08 国际壳牌研究有限公司 处理生物质以产生可用于生物燃料的材料
US8609379B2 (en) 2010-12-20 2013-12-17 Shell Oil Company Process for the production of alcohols from biomass
PL2791344T3 (pl) 2011-12-15 2016-08-31 Shell Int Research Sposób obróbki produktów ubocznych z wytwarzania etanolu
IN2014DN09550A (sh) 2012-05-17 2015-07-17 Shell Int Research
CN103860485A (zh) * 2012-12-18 2014-06-18 深圳市海滨制药有限公司 一种厄他培南钠冻干制剂及其制备方法
CN106232826A (zh) 2014-04-17 2016-12-14 国际壳牌研究有限公司 生产发酵产品的方法
CA2954306C (en) 2014-08-14 2022-08-30 Shell Internationale Research Maatschappij B.V. Process for preparing furfural from biomass

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds

Also Published As

Publication number Publication date
IS4663A (is) 1998-01-27
PL188917B1 (pl) 2005-05-31
HUP9901567A2 (hu) 1999-09-28
ES2208907T3 (es) 2004-06-16
MX9800808A (es) 1998-04-30
IL123078A0 (en) 1998-09-24
CY2437B1 (en) 2004-11-12
NO980380L (no) 1998-03-16
IS2353B (is) 2008-04-15
EP0863901A1 (en) 1998-09-16
HK1016176A1 (en) 1999-10-29
NO323815B1 (no) 2007-07-09
PT863901E (pt) 2004-02-27
EA199800180A1 (ru) 1998-08-27
DE69725696D1 (de) 2003-11-27
CZ25398A3 (cs) 1998-07-15
CZ296381B6 (cs) 2006-03-15
EP0863901B1 (en) 2003-10-22
CA2227994C (en) 2002-06-25
WO1997045430A1 (en) 1997-12-04
DZ2242A1 (fr) 2002-12-18
HUP9901567A3 (en) 2000-03-28
CA2227994A1 (en) 1997-12-04
JPH11509871A (ja) 1999-08-31
EE04678B1 (et) 2006-08-15
CN1198162A (zh) 1998-11-04
NO980380D0 (no) 1998-01-28
PL324746A1 (en) 1998-06-08
TR199800146T1 (xx) 1998-06-22
ATE252584T1 (de) 2003-11-15
HRP970281A2 (en) 1998-06-30
RS49583B (sr) 2007-04-10
ID16974A (id) 1997-11-27
JP2009084284A (ja) 2009-04-23
DK0863901T3 (da) 2004-02-16
EE9800022A (et) 1998-08-17
IL123078A (en) 2002-03-10
KR19990036052A (sh) 1999-05-25
KR100344479B1 (ko) 2002-10-31
HRP970281B1 (en) 2002-04-30
EA000534B1 (ru) 1999-10-28
AU710102B2 (en) 1999-09-16
DE69725696T2 (de) 2004-07-29
HU229426B1 (en) 2013-12-30
CN1067074C (zh) 2001-06-13
BG63821B1 (bg) 2003-02-28
SI0863901T1 (en) 2004-04-30
CO4940412A1 (es) 2000-07-24
JP5255983B2 (ja) 2013-08-07
SK10998A3 (en) 1998-08-05
BG102273A (bg) 1998-09-30
NZ329649A (en) 1998-11-25
AU3077597A (en) 1998-01-05
TW434014B (en) 2001-05-16
KR100403497B1 (ko) 2003-10-30
SK284359B6 (sk) 2005-02-04

Similar Documents

Publication Publication Date Title
YU4198A (sh) Karbapenem antibiotik, kompozicija i postupak za dobijanje
MY115662A (en) Novel compounds with analgesic effect
MY132705A (en) Novel compounds with analgesic effect
CA2274074A1 (en) Novel compounds with analgesic effect
AU6645998A (en) Oxygen or sulfur containing heteroaromatics as factor xa inhibitors
NZ325837A (en) Carbamoyloxy derivatives of mutiline and their use as antibacterials
AU5727899A (en) Diaminocyclobutene-3,4-dione derivatives, their preparation and use
ZA974573B (en) Carbapenem antibiotic, composition and method of preparation.
SE9504662D0 (sv) New compounds
WO2000010998A3 (en) Pyridone antibiotic with improved safety profile
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
AP9801235A0 (en) Erythromycin derivatives.
MY116202A (en) Carbapenem antibiotic, composition and method of preparation
ECSP972136A (es) Composicion y metodo de preparacion de un antibiotico de carbapemen
GR920100423A (el) Ανταγωνιστές 5-ΗΤ4 κινολιζιδινυλ εστέρος.